David N. Adam

426 total citations
29 papers, 257 citations indexed

About

David N. Adam is a scholar working on Dermatology, Immunology and Physiology. According to data from OpenAlex, David N. Adam has authored 29 papers receiving a total of 257 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Dermatology, 8 papers in Immunology and 7 papers in Physiology. Recurrent topics in David N. Adam's work include Dermatology and Skin Diseases (7 papers), Psoriasis: Treatment and Pathogenesis (7 papers) and Asthma and respiratory diseases (3 papers). David N. Adam is often cited by papers focused on Dermatology and Skin Diseases (7 papers), Psoriasis: Treatment and Pathogenesis (7 papers) and Asthma and respiratory diseases (3 papers). David N. Adam collaborates with scholars based in Canada, United States and Denmark. David N. Adam's co-authors include Brian Chan, Nathan Herrmann, Thanashan Rajakulendran, Melinda Gooderham, Perla Lansang, Vimal H. Prajapati, Jennifer Beecker, Charles Lynde, Jensen Yeung and Irina Turchin and has published in prestigious journals such as Nature, SHILAP Revista de lepidopterología and Journal of the American Academy of Dermatology.

In The Last Decade

David N. Adam

28 papers receiving 245 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David N. Adam Canada	9	100	61	52	48	33	29	257
Jiun Yit Pan Singapore	7	61 0.6×	24 0.4×	31 0.6×	112 2.3×	22 0.7×	18	390
Betül Demir Türkiye	11	122 1.2×	12 0.2×	30 0.6×	102 2.1×	27 0.8×	49	333
Heba M. Mashaly Egypt	12	215 2.1×	69 1.1×	28 0.5×	48 1.0×	26 0.8×	24	354
Kenneth A. Beckman United States	11	58 0.6×	47 0.8×	63 1.2×	29 0.6×	32 1.0×	19	406
Osmo Kari Finland	13	186 1.9×	218 3.6×	60 1.2×	20 0.4×	27 0.8×	27	483
Minna E. Kubin Finland	8	203 2.0×	13 0.2×	12 0.2×	26 0.5×	29 0.9×	16	283
Emily Yiping Gan Singapore	10	136 1.4×	7 0.1×	39 0.8×	89 1.9×	31 0.9×	21	294
Mitsuhito Ota Japan	7	292 2.9×	204 3.3×	60 1.2×	33 0.7×	43 1.3×	35	396
Archana Padmanabhan Nair India	11	42 0.4×	27 0.4×	23 0.4×	24 0.5×	8 0.2×	28	334
Pranav Sheth United States	10	177 1.8×	22 0.4×	15 0.3×	61 1.3×	35 1.1×	16	337

Countries citing papers authored by David N. Adam

Since Specialization

Citations

This map shows the geographic impact of David N. Adam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David N. Adam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David N. Adam more than expected).

Fields of papers citing papers by David N. Adam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David N. Adam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David N. Adam. The network helps show where David N. Adam may publish in the future.

Co-authorship network of co-authors of David N. Adam

This figure shows the co-authorship network connecting the top 25 collaborators of David N. Adam. A scholar is included among the top collaborators of David N. Adam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David N. Adam. David N. Adam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Adam, David N.. (2024). Medical AI could be ‘dangerous’ for poorer nations, WHO warns. Nature. 3 indexed citations

Adam, David N., Melinda Gooderham, Jennifer Beecker, et al.. (2023). Expert consensus on the systemic treatment of atopic dermatitis in special populations. Journal of the European Academy of Dermatology and Venereology. 37(6). 1135–1148. 42 indexed citations

Lebwohl, Mark, Linda Stein Gold, Melinda Gooderham, et al.. (2023). CO45 Durability of Efficacy and Safety of Roflumilast Cream 0.3% in Adults with Chronic Plaque Psoriasis from a 52-Week, Phase 2 Open-Label Safety Trial. Value in Health. 26(6). S22–S23. 1 indexed citations

Draelos, Zoe, David N. Adam, Hwanhee Hong, et al.. (2023). Efficacy and safety of roflumilast cream for chronic plaque psoriasis with facial/neck and intertriginous area involvement: a post hoc analysis from a randomized controlled trial. British Journal of Dermatology. 188(6). 810–812. 4 indexed citations

Silverberg, Jonathan I., David N. Adam, Sunil Kalia, et al.. (2022). Tralokinumab Plus Topical Corticosteroids as Needed Provides Progressive and Sustained Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Over a 32-Week Period: An ECZTRA 3 Post Hoc Analysis. American Journal of Clinical Dermatology. 23(4). 547–559. 37 indexed citations

Adam, David N., et al.. (2022). Matching-Adjusted Indirect Comparison of Long-Term Efficacy and Safety Outcomes for Calcipotriol Plus Betamethasone Dipropionate Foam Versus Halobetasol Proprionate Plus Tazarotene Lotion in the Treatment of Plaque Psoriasis. Dermatology and Therapy. 12(11). 2589–2600. 3 indexed citations

Papp, Kim, Chih-ho Hong, Irina Turchin, et al.. (2021). Practical Management of Patients with Atopic Dermatitis on Dupilumab. Dermatology and Therapy. 11(5). 1805–1828. 4 indexed citations

Assaad, Dalal, et al.. (2020). A Rare Variant of a Common Nodule. McGill Journal of Medicine. 13(1). 16–16. 1 indexed citations

Chan, Brian & David N. Adam. (2018). A Review of Fabry Disease.. PubMed. 23(2). 4–6. 34 indexed citations

10.

Adam, David N., et al.. (2018). Pretibial Lymphoplasmacytic Plaque in Children: Case Report and Review of the Literature. American Journal of Dermatopathology. 41(4). 300–302. 1 indexed citations

11.

Adam, David N., et al.. (2015). Tinea Pedis Presenting as Asymmetric Purpuric Papules on the Sole of the Foot: A Case Report. Case Reports in Dermatology. 7(1). 36–38. 2 indexed citations

12.

Adam, David N. & Thanashan Rajakulendran. (2015). Spotlight on pembrolizumab in the treatment of advanced melanoma. Drug Design Development and Therapy. 9. 2883–2883. 9 indexed citations

13.

Pavenski, Katerina, Hilde Vandenberghe, Henry R. Jakubovic, et al.. (2013). Plasmapheresis and Steroid Treatment of Levamisole-Induced Vasculopathy and Associated Skin Necrosis in Crack/Cocaine Users. Journal of Cutaneous Medicine and Surgery. 17(2). 123–128. 17 indexed citations

14.

Jakubovic, Baruch D., et al.. (2012). Occult Cause of Paraneoplastic Acanthosis Nigricans in a Patient with Known Breast Dcis: Case and Review. Current Oncology. 19(4). 299–302. 6 indexed citations

15.

Herrmann, Nathan, et al.. (2011). Transdermal Rivastigmine. CNS Drugs. 25(7). 575–583. 20 indexed citations

16.

Zhang, Junling, et al.. (2008). Efficacy of a Day-Care Program in the Treatment of Psoriasis. Journal of Cutaneous Medicine and Surgery. 12(5). 211–216. 1 indexed citations

17.

Adam, David N., et al.. (2003). Necrolytic Migratory Erythema: Case Report and Clinical Review. Journal of Cutaneous Medicine and Surgery. 7(4). 333–338. 13 indexed citations

18.

Adam, David N.. (2001). More culls planned as Britain wrestles with foot-and-mouth. Nature. 410(6827). 398–398. 2 indexed citations

19.

Adam, David N., et al.. (2000). An Analysis of an Inflammatory Bowel Disease Practise in an Urban Community Hospital. SHILAP Revista de lepidopterología. 14(6). 483–488. 2 indexed citations

20.

Roger, G., et al.. (1998). Pharyngo-laryngeal histoplasmosis: one case in an immunocompetent child. International Journal of Pediatric Otorhinolaryngology. 45(2). 177–181. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact